The Value of Medicine
A recent report from Eli Lilly focused on “The Value of Medicine,” and how pharmaceutical companies are dedicated to the discovery…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
NY Times: Antipsychotics and the Legal Industries Side Effects
There are risks and benefits to everything in life, and the drugs that pharmaceutical companies make are no exception. The Food…
Massachusetts Gubernatorial Candidates Unanimously Support Repeal of the…
In politics it is rare for politicians running for the same off office to agree on anything. But this week a unique agreement…
21st Annual Conference of the National Task Force on CME Provider/Industry…
The 21st Annual Conference of the National Task Force on CME Provider/Industry Collaboration will be held October 13–15 in…
Patient Centered Outcomes Research Institute: Names their Board of…
Within the Patient Protection and Affordable Care Act , Congress created a Patient-Centered Outcomes Research Institute (PCORI).…
The Ghosts behind the Ghosts: Trial Attorneys and the Ghost Writing…
Transparency and disclosure are the key elements necessary to ensure that the public and other clinicians can fairly evaluate the…
Healthcare Leadership Council: National Dialogue for Healthcare Innovation
Today, The Healthcare Leadership Council (HLC), a coalition of chief executives representing all sectors of American healthcare,…
Novartis Trileptal $422.5 Million Settlement and Corporate Integrity…
The Department of Justice (DOJ) announced that Novartis Pharmaceuticals Corporation has agreed to pay $422.5 million to resolve…
New York Times: Clinical Trial Subjects and Hard Choices
Doctors make extremely difficult decisions every day. It is one of the hardest parts of their job. They must choose whether…
Cleveland Clinic’s Guy Chisolm: Physician Industry Collaboration and…
During a recent interview, Dr. Guy Chisolm, Director of the Innovation Management and Conflict of Interest program at the…